noMD VEH | noMD MIF | MD VEH | MD MIF | Condition × treatment | Condition (noMD vs MD) | Treatment (VEH vs MIF) | |
---|---|---|---|---|---|---|---|
Hippocampus | |||||||
Amplitude (pA) | 18.9 ± 0.8 | 18.1 ± 0.6 | 18 ± 0.6 | 18.1 ± 0.7 | F(3,61) = 0.5; p = 0.459 | F(3,61) = 0.4; p = 0.525 | F(3,61) = 0.2; p = 0.634 |
τ-Rise (ms) | 4.2 ± 0.2 | 3.8 ± 0.2 | 3.7 ± 0.3 | 3.9 ± 0.2 | F(3,62) = 2.3; p = 0.132 | F(3,62) = 0.5; p = 0.483 | F(3,62) = 0.1; p = 0.699 |
τ-Decay (ms) | 11.6 ± 0.6 | 11.4 ± 0.7 | 11.2 ± 0.7 | 11.3 ± 0.7 | F(3,62) = 0.0; p = 0.807 | F(3,62) = 02.; p = 0.688 | F(3,62) = 0.0; p = 0.896 |
Dorsomedial striatum | |||||||
Amplitude (pA) | 16.1 ± 1.3 | 16.7 ± 0.7 | 12.3 ± 0.9 | 15.7 ± 0.9 | F(1,48) = 2.0; p = 0.161 | F(1,48) = 5.7; p = 0.020 | F(1,48) = 3.9; p = 0.052 |
τ-Rise (ms) | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 | F(1,48) = 0.0; p = 0.940 | F(1,48) = 2.2; p = 0.139 | F(1,48) = 0.3; p = 0.860 |
τ-Decay (ms) | 6.2 ± 0.5 | 6.2 ± 0.5 | 4.7 ± 0.4 | 5.5 ± 0.5 | F(1,48) = 0.6; p = 0.424 | F(1,48) = 5.2; p = 0.027 | F(1,48) = 0.5; p = 0.483 |
Half of the animals were treated twice daily with MIF through oral gavage on PND26–PND28.